Equine Matrix Metalloproteinase 13 (MMP13) ELISA Kit

The Assay Genie equine matrix metalloproteinase 13 (MMP13) immunoassay is supplied as a research-use-only kit for quantifying collagenase-3 in horse-derived specimens. MMP13 is a zinc-dependent endopeptidase that cleaves type II collagen in articular cartilage; in horses, elevated concentrations are associated with osteoarthritis, joint inflammation, and tendon pathology, making it a useful biomarker in equine musculoskeletal research.

Each kit is supplied in a microplate format with all reagents required for an in vitro colorimetric ELISA workflow. The assay accepts tissue homogenates and other equine sample matrices, and results can be paired with western blot confirmation or immunohistochemistry on cartilage explants to characterize joint degeneration. Reconstituted reagents should be aliquoted to limit repeated freeze-thaw cycles, and stored according to the protocol included with the kit.

The reagents are intended for research use only in laboratory settings and have been validated for equine samples. Researchers studying equine joint disease, articular cartilage erosion, or matrix remodeling will find this kit useful for monitoring MMP13 concentrations across disease models and treatment interventions.